VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

CPT-3 in Normal Pressure Hydrocephalus

Terminated

Conditions: Normal Pressure Hydrocephalus

First Posted Date: 2018-05-11

Last Posted Date: 2023-07-27

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 8

Registration Number: NCT03521518

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

PRecision Interventions for SMoking in the SCCS

Phase 2

Completed

Conditions: Tobacco Use Cessation

Interventions: Drug: Nicotine patch
Drug: Varenicline
Genetic: Nicotine metabolism
Genetic: Genetically-informed lung cancer risk score
Behavioral: NCI "Clearing the Air"

First Posted Date: 2018-05-11

Last Posted Date: 2020-06-01

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 67

Registration Number: NCT03521141

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Collaborative Assessment of ICU Recovery Needs

Completed

Conditions: Post-Intensive Care Syndrome

Interventions: Other: Patient, Carer, and Clinician Interviews

First Posted Date: 2018-05-01

Last Posted Date: 2020-02-18

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 66

Registration Number: NCT03513289

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇦🇺
Australian and New Zealand Intensive Care Research Centre, Melbourne, Victoria, Australia

Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection

Phase 4

Terminated

Conditions: Urinary Tract Infections
Overactive Bladder

Interventions: Drug: Periprocedural Antibiotics
Procedure: Injection of OnabotulinumtoxinA (BTX-A)
Drug: Extended Antibiotics

First Posted Date: 2018-04-26

Last Posted Date: 2023-11-02

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 22

Registration Number: NCT03508921

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

CrYobiopsy With Radial UltraSound Guidance

Not Applicable

Completed

Conditions: Pulmonary Disease

Interventions: Device: Flouroscopy
Device: Radial Endobronchial Ultrasound Probe

First Posted Date: 2018-04-24

Last Posted Date: 2019-11-12

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 10

Registration Number: NCT03506295

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Imaging Activated Macrophages in the Lungs

Phase 1

Terminated

Conditions: COPD

Interventions: Drug: Ga-EC2115

First Posted Date: 2018-04-11

Last Posted Date: 2021-08-11

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 13

Registration Number: NCT03494114

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

The Impact of Branched-Chain Amino Acid Metabolism on Limb Dysfunction in PAD

Not Applicable

Completed

Conditions: Peripheral Arterial Disease

Interventions: Behavioral: Supervised Exercise
Behavioral: Vascular Assessment

First Posted Date: 2018-04-06

Last Posted Date: 2024-02-29

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 80

Registration Number: NCT03490968

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Evaluation of a Daily Brief Exercise Intervention on Resident Physician Personal Resiliency and Burnout

Not Applicable

Completed

Conditions: Burnout, Professional
Burnout Syndrome

Interventions: Behavioral: Prescribed Exercise Program
Behavioral: Usual Exercise Program

First Posted Date: 2018-04-05

Last Posted Date: 2020-04-14

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 46

Registration Number: NCT03489720

Locations: 🇺🇸
Vanderbilt Unversity Medical Center, Nashville, Tennessee, United States

Soluble Epoxide Hydrolase Inhibition and Insulin Resistance

Phase 2

Completed

Conditions: Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
PreDiabetes
Obesity

Interventions: Drug: GSK2256294
Drug: Placebo oral capsule

First Posted Date: 2018-04-03

Last Posted Date: 2023-03-23

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 16

Registration Number: NCT03486223

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Automated Abdominal Binder for Orthostatic Hypotension

Phase 1

Recruiting

Conditions: Multiple System Atrophy
Autonomic Failure
Orthostatic Hypotension
Pure Autonomic Failure

Interventions: Device: automated abdominal binder
Device: Sham binder
Drug: Placebo
Drug: Midodrine

First Posted Date: 2018-03-29

Last Posted Date: 2024-10-31

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 31

Registration Number: NCT03482297

Locations: 🇺🇸
Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy